Attorney Natalie Moszczynski is a valuable ally for physicians and health care and life sciences organizations, guiding them through corporate, transactional, and regulatory matters.
Natalie represents clients in all corporate matters, including mergers, acquisitions, and sales of medical practices, pharmaceutical companies, physical therapy practices, and pharmacies, from the initial letters of intent and due diligence through closing. She also assists clients in analyzing health care transactions for compliance with the federal Stark Law, the federal Anti-Kickback Statute, and state physician self-referral and state anti-kickback laws.
In addition to Natalie’s corporate and health care practice, she advises companies, such as start-ups and multistate operators, on issues associated with regulatory and licensure compliance in operating state-legalized cannabis businesses and considerations associated with anticipated mergers and acquisitions of such businesses.
During law school, Natalie served as an intern to the Honorable Judge Stephen L. Petrillo in the Civil Division of the Superior Court of New Jersey.
- Rutgers Law School (J.D., 2021)
- Managing Editor, Rutgers Law Record
- Duke University (B.A., 2018)
- House Course Instructor and Intern, The Duke Center for Personalized Health Care
- New Jersey
- “Biden’s Pardon and Its Future Impact on Cannabis: A Federal Update,” New Jersey Lawyer Magazine, November 1, 2022
- “Magic Mushrooms in the Garden State? A Look Into the Proposed Psilocybin Legal Landscape in New Jersey,” New Jersey Lawyer Magazine, September 21, 2022
- “Defining Privacy of Biometric Information: Legislative Approaches to Growing Use of Biometrics in Our Society and What it Means for Businesses,” New Jersey Lawyer Magazine, August 2022
- “The Latest on Taxation of New Jersey Cannabis,” New Jersey Law Journal, August 4, 2022
- “Historic First Day of Personal Adult-Use Sales and Preservation of Medicinal Cannabis Market,” New Jersey Law Journal, May 13, 2022
- “The Adult Use Cannabis License Application Opened Two Months Ago: What Comes Next?” New Jersey Law Journal, February 22, 2022
- “Personal Adult-Use Cannabis: Business License Applications Are Finally Here,” New Jersey Law Journal, January 6, 2022
- “Declassifying Cannabis as a Schedule 1 Drug: How Can It Be Done and What Will the Effects Be?” New Jersey Law Journal, November 30, 2021